TNXP Tonix Pharmaceuticals Holding Corp
- Stocks
- Healthcare
- NASDAQ: TNXP
Price (delayed)
$20
Market cap
$128.7M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$176.6
Enterprise value
$38.04M
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix's
Highlights
TNXP's quick ratio has soared by 164% from the previous quarter
TNXP's EPS has soared by 99% YoY and by 94% from the previous quarter
TNXP's gross margin is down by 41% YoY but it is up by 12% from the previous quarter
The company's revenue rose by 30% YoY but it fell by 11% QoQ
The gross profit has contracted by 23% YoY
Key stats
What are the main financial stats of TNXP
Market
Valuations
Earnings
Shares outstanding
6.43M
Market cap
$128.7M
Enterprise value
$38.04M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.27
Price to sales (P/S)
1.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.77
Revenue
$10.09M
Gross profit
$2.33M
Operating income
-$136.7M
Net income
-$130.04M
EBIT
-$130.04M
EBITDA
-$126.62M
Free cash flow
-$61.05M
Per share
Balance sheet
Liquidity
EPS
-$176.6
EPS diluted
-$176.6
Free cash flow per share
-$82.9
Book value per share
$74.67
Revenue per share
$13.71
TBVPS
$221.05
Total assets
$162.89M
Total liabilities
$23.33M
Debt
$8.12M
Equity
$139.56M
Working capital
$100.7M
Debt to equity
0.06
Current ratio
6.5
Quick ratio
5.6
Net debt/EBITDA
0.72
Margins
Efficiency
Dividend
EBITDA margin
-1,254.4%
Gross margin
23.1%
Net margin
-1,288.3%
Operating margin
-1,354.3%
Return on assets
-112.2%
Return on equity
-142.9%
Return on invested capital
-189.6%
Return on capital employed
-89.9%
Return on sales
-1,288.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TNXP stock price
How has the Tonix Pharmaceuticals Holding stock price performed over time
Intraday
10.86%
1 week
12.23%
1 month
15.01%
1 year
-96.35%
YTD
-39.36%
QTD
11.89%
Financial performance
How have Tonix Pharmaceuticals Holding's revenue and profit performed over time
Revenue
$10.09M
Gross profit
$2.33M
Operating income
-$136.7M
Net income
-$130.04M
Gross margin
23.1%
Net margin
-1,288.3%
TNXP's gross margin is down by 41% YoY but it is up by 12% from the previous quarter
The company's revenue rose by 30% YoY but it fell by 11% QoQ
The gross profit has contracted by 23% YoY
Tonix Pharmaceuticals Holding's operating income has decreased by 15% YoY but it has increased by 3.4% from the previous quarter
Growth
What is Tonix Pharmaceuticals Holding's growth rate over time
Valuation
What is Tonix Pharmaceuticals Holding stock price valuation
P/E
N/A
P/B
0.27
P/S
1.46
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.77
TNXP's EPS has soared by 99% YoY and by 94% from the previous quarter
The P/B is 170% higher than the last 4 quarters average of 0.1 but 55% lower than the 5-year quarterly average of 0.6
The company's equity has surged by 88% QoQ and by 32% YoY
The company's revenue rose by 30% YoY but it fell by 11% QoQ
TNXP's P/S is 22% above its last 4 quarters average of 1.2
Efficiency
How efficient is Tonix Pharmaceuticals Holding business performance
TNXP's return on invested capital has dropped by 69% year-on-year and by 16% since the previous quarter
The company's return on equity has shrunk by 63% YoY but it rose by 13% QoQ
TNXP's ROA has shrunk by 52% YoY but it is up by 6% QoQ
TNXP's ROS is up by 14% YoY but it is down by 8% from the previous quarter
Dividends
What is TNXP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TNXP.
Financial health
How did Tonix Pharmaceuticals Holding financials performed over time
TNXP's quick ratio has soared by 164% from the previous quarter
The current ratio has surged by 157% year-on-year and by 95% since the previous quarter
The debt is 94% smaller than the equity
The company's equity has surged by 88% QoQ and by 32% YoY
The debt to equity has plunged by 50% from the previous quarter and by 33% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.